1. Association AD. Diagnosis and classification of diabetes mellitus. Diabetes care. 2010; 33 Suppl 1: S62-S69.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87(1): 4-14.
3. Kuncorojakti S, Rodprasert W, Yodmuang S, Osathanon T, Pavasant P, Srisuwatanasagul S, et al. Alginate/Pluronic F127-based encapsulation supports viability and functionality of human dental pulp stem cell-derived insulin-producing cells. J Biol Eng. 2020; 14(1): 1-15.
4. Pokrywczynska M, Krzyzanowska S, Jundzill A, Adamowicz J, Drewa T. Differentiation of stem cells into insulin-producing cells: current status and challenges. Arch Immunol Ther Exp (Warsz). 2013; 61(2): 149-158.
5. Yu S, Li C, Hou Xg, Hou Wk, Dong JJ, Lei S, et al. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cellsin vitro. Chin Med J. 2007; 120(9): 771-776.
6. Yakhkeshi S, Rahimi S, Sharafi M, Hassani SN, Taleahmad S, Shahverdi A, et al. In vitro improvement of quail primordial germ cell expansion through activation of TGF-beta signaling pathway. J Cell Biochem. 2018; 119(6): 4309-4319.
7. Schiesser JV, Wells JM. Generation of β cells from human pluripotent stem cells: are we there yet? Ann N Y Acad Sci. 2014; 1311: 124-137.
8. Chmielowiec J, Borowiak M. In vitro differentiation and expansion of human pluripotent stem cell-derived pancreatic progenitors. Rev Diabet Stud. 2014; 11(1): 19-34.
9. Moshtagh PR, Emami SH, Sharifi AM. Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study. J Physiol Biochem. 2013; 69(3): 451-458.
10. Hu J, Yu X, Wang Z, Wang F, Wang L, Gao H, et al. Long term effects of the implantation of Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J. 2013; 60(3): 347-357.
11. Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X, et al. Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med. 2011; 5(1): 94-100.
12. Andersen T, Auk-Emblem P, Dornish M. 3D cell culture in alginate hydrogels. Microarrays. 2015; 4(2): 133-161.
13. Kin K, Yasuhara T, Kameda M, Tomita Y, Umakoshi M, Kuwahara K, et al. Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats. Mol Psychiatry. 2020; 25(6): 1202-1214.
14. Sarker B, Rompf J, Silva R, Lang N, Detsch R, Kaschta J, et al. Alginate-based hydrogels with improved adhesive properties for cell encapsulation. Int J Biol Macromol. 2015; 78: 72-78.
15. Sun J, Tan H. Alginate-based biomaterials for regenerative medicine applications. Materials. 2013; 6(4): 1285-1309.
16. Choi S, Kim JH, Ha J, Jeong BI, Jung YC, Lee GS, et al. Intraarticular injection of alginate-microencapsulated adipose tissuederived mesenchymal stem cells for the treatment of osteoarthritis in rabbits. Stem Cells Int. 2018; 2018.
17. Strand BL, Coron AE, Skjak-Braek G. Current and future perspectives on alginate encapsulated pancreatic islet. Stem Cells Transl Med. 2017; 6(4): 1053-1058.
18. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science. 1980; 210(4472): 908-910.
19. Kumar SR, Markusic DM, Biswas M, High KA, Herzog RW. Clinical development of gene therapy: results and lessons from recent successes. Mol Ther Methods Clin Dev. 2016; 3: 16034.
20. Tsokos GC, Nepom GT. Gene therapy in the treatment of autoimmune diseases. J Clin Invest. 2000; 106(2): 181-183.
21. Allahverdi A, Abroun S, Jafarian A, Soleimani M, Taghikhani M, Eskandari F. Differentiation of human mesenchymal stem cells into insulin producing cells by using a lentiviral vector carrying PDX1. Cell J. 2015; 17(2): 231.
22. Gerace D, Martiniello-Wilks R, Simpson A. Diabetes reversal via gene transfer: building on successes in animal models. Res Rep Endocr Disord. 2015; 5: 15-29
23. Varaa N, Azandeh S, Khodabandeh Z, Gharravi AM. Wharton’s jelly mesenchymal stem cell: Various protocols for isolation and differentiation of hepatocyte-like cells; narrative review. Iran J Med Sci. 2019; 44(6): 437-448.
24. Noguchi H, Xu G, Matsumoto S, Kaneto H, Kobayashi N, Bonner-Weir S, et al. Induction of pancreatic stem/progenitor cells into insulin-producing cells by adenoviral-mediated gene transfer technology. Cell Transplant. 2006; 15(10): 929-938.
25. Kanafi MM, Ramesh A, Gupta PK, Bhonde RR. Dental pulp stem cells immobilized in alginate microspheres for applications in bone tissue engineering. Int Endod J. 2014; 47(7): 687-697.
26. Gabr MM, Zakaria MM, Refaie AF, Abdel-Rahman EA, Reda AM, Ali SS, et al. From human mesenchymal stem cells to insulinproducing cells: comparison between bone marrow-and adipose tissue-derived cells. Biomed Res Int. 2017; 2017.
27. Fiorina P, Voltarelli J, Zavazava N. Immunological applications of stem cells in type 1 diabetes. Endocr Rev. 2011; 32(6): 725-754.
28. El-Badawy A, El-Badri N. Clinical efficacy of stem cell therapy for diabetes mellitus: a meta-analysis. PLoS One. 2016; 11(4): e0151938.
29. Czubak P, Bojarska-Junak A, Tabarkiewicz J, Putowski L. A modified method of insulin producing cells’ generation from bone marrow-derived mesenchymal stem cells. J Diabetes Res. 2014; 2014: 628591.
30. Ranjbaran H, Abediankenari S, Amiri MM. Enhanced differentiation of whartonâ s jelly-derived mesenchymal stem cells in insulin-producing cells by the extract of nigella sativa seeds. Iran Red Crescent Med J. 2018; 20(3).
31. Sharma A, Rani R. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells. Stem Cell Res Ther. 2017; 8(1): 167.
32. Rahmati S, Alijani N, Kadivar M. In vitro generation of glucose-responsive insulin producing cells using lentiviral based pdx-1 gene transduction of mouse (C57BL/6) mesenchymal stem cells. Biochem Biophys Res Commun. 2013; 437(3): 413-419.
33. Soltanian A, Ghezelayagh Z, Mazidi Z, Halvaei M, Mardpour S, Ashtiani MK, et al. Generation of functional human pancreatic organoids by transplants of embryonic stem cell derivatives in a 3Dprinted tissue trapper. J Cell Physiol. 2019; 234(6): 9564-9576.
34. Lima MJ, Muir KR, Docherty HM, McGowan NW, Forbes S, Heremans Y, et al. Generation of functional beta-like cells from human exocrine pancreas. PLoS One. 2016; 11(5): e0156204.
35. Barati G, Nadri S, Hajian R, Rahmani A, Mostafavi H, Mortazavi Y, et al. Differentiation of microfluidic-encapsulated trabecular meshwork mesenchymal stem cells into insulin producing cells and their impact on diabetic rats. J Cell Physiol. 2019; 234(5): 6801-6809.
36. Alagpulinsa DA, Cao JJ, Driscoll RK, Sîrbulescu RF, Penson MF, Sremac M, et al. Alginate-microencapsulation of human stem cell–derived β cells with CXCL 12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression. Am J Transplant. 2019; 19(7): 1930-1940.
37. Khatab S, Leijs MJ, van Buul G, Haeck J, Kops N, Nieboer M, et al. MSC encapsulation in alginate microcapsules prolongs survival after intra-articular injection, a longitudinal in vivo cell and bead integrity tracking study. Cell Biol Toxicol. 2020; 36(6): 553-570.
38. Duruksu G, Polat S, Kayiş L, Gürcan NE, Gacar G, Yazir Y. Improvement of the insulin secretion from beta cells encapsulated in alginate/poly-L-histidine/alginate microbeads by platelet-rich plasma. Turk J Biol. 2018; 42(4): 297-306.
39. Tsai PJ, Wang HS, Lin GJ, Chou SC, Chu TH, Chuan WT, et al. Undifferentiated Wharton’s jelly mesenchymal stem cell transplantation induces insulin-producing cell differentiation and suppression of T-cell-mediated autoimmunity in nonobese diabetic mice. Cell Transplant. 2015; 24(8): 1555-1570.
40. De Mesmaeker I, Robert T, Suenens KG, Stangé GM, Van Hulle F, Ling Z, et al. Increase functional β-cell mass in subcutaneous alginate capsules with porcine prenatal islet cells but loss with human adult islet cells. Diabetes. 2018; 67(12): 2640-2649.